Concomitant Radiochemotherapy plus Surgery in Locally Advanced Cervical Cancer: Update of Clinical Outcome and Cyclooxygenase-2 as Predictor of Treatment Susceptibility
暂无分享,去创建一个
G. Scambia | G. Ferrandina | R. Manfredi | G. Macchia | N. Cellini | G. Zannoni | D. Smaniotto | M. Distefano | M. Mangiacotti | A. P. Margariti
[1] G. Scambia,et al. Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery. , 2003, International journal of radiation oncology, biology, physics.
[2] N. Maggiano,et al. Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications , 2002, British Journal of Cancer.
[3] C. Suh,et al. Overexpression of cyclooxygenase‐2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy , 2002, Cancer.
[4] N. Maggiano,et al. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] L Souhami,et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Isola,et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. , 2002, Cancer research.
[7] F. Landoni,et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] G. Scambia,et al. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients? , 2001, Gynecologic oncology.
[9] A. Hsu,et al. Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells. , 2001, Advances in enzyme regulation.
[10] D. Beer,et al. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. , 2000, Cancer research.
[11] V. Valentini,et al. Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. , 2000, Gynecologic oncology.
[12] P. Grigsby,et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. García-Foncillas,et al. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer. , 1999, Gynecologic oncology.
[14] B N Bundy,et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] B N Bundy,et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. , 1999, The New England journal of medicine.
[16] P J Eifel,et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.
[17] K. Blank,et al. Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer , 1999 .
[18] R. Manfredi,et al. Cervical cancer response to neoadjuvant therapy: MR imaging assessment. , 1998, Radiology.
[19] R. DuBois,et al. Prostaglandin endoperoxide synthase: why two isoforms? , 1996, The American journal of physiology.
[20] M. Gamerre,et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. , 1994, Gynecologic oncology.
[21] W. Sauerbrei,et al. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.
[22] M. Piver,et al. Five Classes of Extended Hysterectomy for Women With Cervical Cancer , 1974, Obstetrics and gynecology.
[23] David R. Cox. The analysis of binary data , 1970 .
[24] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[25] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .